Proteomics analysis of changes in myocardial proteins during endotoxemia

Journal of Proteomics

Volumn 72, Issue 4, 2009, Pages 648-655

  Robichaud, Sophie ^a   Lalu, Manoj ^b   Udenberg, Tanner ^b   Schulz, Richard ^b   Sawicki, Grzegorz ^c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Endotoxemia; Metabolic enzymes; Myocardial dysfunction; Proteomics; Sepsis

Indexed keywords

ALBUMIN; DIENOYL COENZYME A ISOMERASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 27; NITRITE; PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; HEART FAILURE; MALE; MEAN ARTERIAL PRESSURE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; RAT; SEPSIS;

AMINO ACID SEQUENCE; ANIMALS; BLOOD PRESSURE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDOTOXEMIA; LIPOPOLYSACCHARIDES; MALE; MOLECULAR SEQUENCE DATA; MYOCARDIUM; NITRITES; PROTEOME; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 63649091660     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2009.01.010     Document Type: Article

References (48)

1. Martin G.S., Mannino D.M., Eaton S., and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (2003) 1546-1554
2. Sharma A.C., Motew S.J., Farias S., Alden K.J., Bosmann H.B., Law W.R., et al. Sepsis alters myocardial and plasma concentrations of endothelin and nitric oxide in rats. J Mol Cell Cardiol 29 (1997) 1469-1477
3. Parrilo J.E., Parker M.M., Natanson C., Suffredini A.F., Danner R.L., Cunnion R.E., et al. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113 (1990) 227-242
4. Calandra T., Echtenacher B., Le Roy D., Pugin J., Metz C.N., Hültner L., et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 6 (2000) 164-170
5. Kilbourn R.G., Traber D.L., and Szabo C. Nitric oxide and shocks. Dis Mon 43 (1997) 277-348
6. Albert J., Radomski A., Soop A., Sollevi A., Frostell C., and Radomski M.W. Differential release of matrix metalloproteinase-9 and nitric oxide following infusion of endotoxin to human volunteers. Acta Anaesthesiol Scand 47 (2003) 407-410
7. Ramon A., and Kumar A. Human endotoxemia and human sepsis: limits to the model. Crit Care 9 (2005) 151-152
8. Parker S.J., and Watkins P.E. Experimental models of Gram-negative sepsis. Br J Surg 88 (2001) 22-30
9. Richard P., Cook D., Roger B., and William S.J. Introducing critical appraisal to studies of animal models investigating novel therapies in sepsis. Crit Care Med 24 (1996) 2059-2070
10. Lang C.H., Frost R.A., and Vary T.C. Regulation of muscle protein synthesis during sepsis and inflammation. Am J Physiol Endocrinol Metab 293 (2007) E453-E459
11. Vary T.C., and Kimball S.R. Regulation of hepatic protein synthesis in chronic inflammation and sepsis. Am J Physiol Cell Physiol 262 (1992) C445-C452
12. Biolo G., Toigo G., Beniamino C., Situlin R., Iscra F., Gullo A., et al. Metabolic response to injury and sepsis: changes in protein metabolism. Nutrition 13 (1997) 52-57
13. Freeman B.D., and Natanson C. Clinical trials in sepsis and septic shock in 1994 and 1995. Curr Opin Crit Care 1 (1995) 349-357
14. Friedman G., Gomez J., Shahla M., and Vincent J.L. Mortality from septic shock: have we made progress?. Abstr Am J Respir Crit Care Med A151 (1995) A494
15. Khadour F.H., Panas D., Ferdinandy P., Schulze C., Csont T., Lalu Manoj M., et al. Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats. Am J Physiol Heart Circ Physiol 283 (2002) H1108-H1115
16. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 126 (1982) 131-138
17. Herbertson M.J., Werner H.A., Wolfgang S., Russell J.A., and Walley K.R. Decreased left ventricular contractility during porcine endotoxemia is not prevented by ibuprofen. Crit Care Med 24 (1996) 815-819
18. Wang W., Falk S.A., Jittikanont S., Gengargo P.E., Edelstein C.L., and Schrier R.W. Protective effect of renal denervation on normotensive endotoxemia-induced acute renal failure in mice. J Am Soc Nephrol 283 (2002) F583-F587
19. Sawicki G., Leon H., Sawicka J., Sariahmetoglu M., Schulze C.J., Scott P.G., et al. Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury, a new intracellular target for matrix metalloproteinase-2. Circ 112 (2005) 544-552
20. Sawicki G., Dakour J., and Morrish D.W. Functional proteomics of neurokinin B in the placenta indicates a novel role in regulating cytotrophoblast antioxidant defences. Proteomics 3 (2003) 2044-2051
21. Perkins D.N., Pappin D.J., Creasy D.M., and Cottrell J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20 (1999) 3551-3567
22. Dunn M.J. Studying heart disease using the proteomic approach. Drug Discov Today 5 (2000) 76-84
23. Arrell D.K., Neverova I., Fraser H., Marban E., and Van Eyk J.E. Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1. Circ Res 89 (2001) 480-487
24. Scheler C., Li X.P., Salnikow J., Dunn M.J., and Jungblut P.R. Comparison of two-dimensional electrophoresis patterns of heat shock protein Hsp27 species in normal and cardiomyopathic hearts. Electrophoresis 20 (1999) 3623-3628
25. Arrell D.K., Neverova I., and Van Eyk J.E. Cardiovascular proteomics: evolution and potential. Circ Res 88 (2001) 763-773
26. Jager D., Jungblut P.R., and Muller-Werdan U. Separation and identification of human heart proteins. J Chromatogr B Analyt Technol Biomed Life Sci 771 (2001) 131-153
27. Corbett J.M., Why H.J., Wheeler C.H., Richardson P.J., Archard L.C., Yacoub M.H., et al. Cardiac protein abnormalities in dilated cardiomyopathy detected by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 19 (1998) 2031-2042
28. Foster D.B., and Van Eyk J.E. In search of the proteins that cause myocardial stunning. Circ Res 85 (1999) 470-472
29. Schwertz H., Langin T., Platsch H., Richert J., Bomm S., Schmidt M., et al. Two-dimensional analysis of myocardial protein expression following myocardial ischemia and reperfusion in rabbits. Proteomics 2 (2002) 988-995
30. Jiang L., Tsubakihara M., Heinke M.Y., Yao M., Dunn M.J., Phillips W., et al. Heart failure and apoptosis: electrophoretic methods support data from micro- and macro-arrays. A critical review of genomics and proteomics. Proteomics 1 (2001) 1481-1488
31. Landgarten M.J., Kumar A., and Parrillo J.E. Cardiovascular dysfunction in sepsis and septic shock. Curr Treat Options Cardiovasc Med 2 (2000) 451-459
32. Court O., Kumar A., Parrillo J.E., and Kumar A. Clinical review: myocardial depression in sepsis and septic shock. Crit Care 6 (2002) 500-508
33. Bannerman D.D., and Goldblum S.E. Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol 284 (2003) L899-L914
34. Vary T., and Kimball S. Sepsis-induced changes in protein synthesis: differential effects on fast and slow twitch muscles. Am J Physiol Cell Physiol 262 (1992) C1513-C1519
35. Hallemeesch M.M., Soeters P.B., and Deutz N.E.P. Renal arginine and protein synthesis are increased during early endotoxemia in mice. Am J Physiol Renal Physiol 282 (2002) F316-F323
36. Orellana R.A., Kimball S.R., Nguyen H.V., Bush J.A., Suryawan A., Thivierge M.C., et al. Regulation of muscle protein synthesis in neonatal pigs during prolonged endotoxemia. Pediatr Res 55 (2004) 442-449
37. Schroeder S., Reck M., Hoeft A., and Stuber F. Analysis of two human leukocyte antigen-linked polymorphic heat shock protein 70 genes in patients with severe sepsis. Crit Care Med 27 (1999) 1265-1270
38. Hashiguchi N., Ogura H., Tanaka H., Koi T., Nakamori Y., Noborio M., et al. Enhanced expression of heat shock proteins in activated polymorphonuclear leukocytes in patients with sepsis. J Trauma 51 (2001) 1104-1109
39. Naoyuki H., Hiroshi O., Hiroshi T., Taichin K., Yasushi N., Mitsuhiro N., et al. Enhanced expression of heat shock proteins in activated polymorphonuclear leukocytes in patients with sepsis. J Trauma 51 (2001) 1104-1109
40. Fert-Bober J., Basran R.S., Sawicka J., and Sawicki G. Effect of duration of ischemia on myocardial proteome in ischemia/reperfusion injury. Proteomics 8 (2008) 2543-2555
41. Fert-Bober J., Leon H., Sawicka J., Basran R.S., Devon R.M., Schulz R., et al. Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion. Basic Res Cardiol 103 (2008) 431-443
42. Matsuda N., and Yuichi H. Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. J Smooth Muscle Res 43 (2007) 117-137
43. Premer D.M., Goertz1 R., Georgieff M.K., Mammel M.C., and Schwarzenberg S.J. Muscle proteolysis and weight loss in a neonatal rat model of sepsis syndrome. Inflammation 26 (2002) 97-101
44. Lalu M.M., Gao C.Q., and Schulz R. Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9. Mol Cell Biochem 251 (2003) 61-66
45. Lalu M.M., Csont T., and Schulz R. Matrix metalloproteinase activities are altered in the heart and plasma during endotoxemia. Crit Care Med 32 (2004) 1332-1337
46. Lalu M.M., Cena J., Chowdhury R., Lam A., and Schulz R. Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction. Br J Pharmacol 149 (2006) 31-42
47. Kunau W., Dommes V., and Schulz H. Beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress. Prog Lipid Res 34 (1995) 267-342
48. Crouser E. Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion 4 (2004) 729-741